Nu Skin Enterprises, Inc. (NUS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nu Skin Enterprises, Inc. (NUS) trades at $5.03 with AI Score 78/100 (Grade A). Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products globally, focusing on skincare, nutritional supplements, and weight management. Market cap: $244.21M, Sector: Consumer defensive.
Price live · AI analysis from May 10, 2026Analyst Coverage for NUS: NUS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NUS against Consumer Defensive peers across nine fundamental dimensions and assigns a relatively strong fundamental profile based on the underlying data.
NUS: 1/1 perspectives are bullish.
How is this calculated? →Nu Skin Enterprises, Inc. (NUS) Consumer Business Overview
Nu Skin Enterprises develops and distributes beauty and wellness products, emphasizing skincare and nutritional supplements. With a direct-selling model and a global presence, the company competes in the household and personal products sector, balancing innovation with market demand and regulatory changes.
What Is the Investment Thesis for NUS?
Nu Skin Enterprises, Inc. presents a mixed investment profile. With a P/E ratio of 4.7 and a dividend yield of 3.35%, the company offers potential value and income. However, a relatively low profit margin of 3.8% indicates challenges in profitability. Key growth catalysts include expansion in emerging markets and continued innovation in skincare and nutritional products. The company's direct selling model faces risks from changing consumer preferences and regulatory scrutiny. Investors should monitor Nu Skin's ability to adapt to these challenges and capitalize on its brand recognition and global distribution network.
Based on FMP financials and quantitative analysis
NUS Key Highlights
- Market Cap of $244.21M reflects its current valuation in the beauty and wellness market.
- P/E Ratio of 4.7 indicates potential undervaluation compared to industry peers.
- Gross Margin of 69.3% demonstrates strong pricing power and efficient cost management.
- Dividend Yield of 3.35% provides an attractive income stream for investors.
- Beta of 1.07 suggests the stock's volatility is slightly higher than the market average.
Who Are NUS's Competitors?
NUS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HLTH Cue Health Inc. | $0.04 | -29.77% | $6.90M | 44 |
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| SGI Somnigroup International Inc | $78.20 | -0.29% | $16.45B | 62 |
| ELF e.l.f. Beauty, Inc. | $74.33 | -2.73% | $4.42B | 59 |
| MIOFF Milbon Co., Ltd. | $52.60 | +0.00% | $1.71B | 58 |
| NBBTF Natural Beauty Bio-Technology Limited | $0.06 | +0.00% | $122.13M | 57 |
| CL Colgate-Palmolive Company | $93.00 | -2.24% | $74.42B | 57 |
| LIOPF Lion Corporation | $11.51 | +0.00% | $3.18B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NUS's Key Strengths?
- Strong brand recognition in the beauty and wellness industry.
- Proprietary ageLOC technology.
- Established global distribution network.
- Direct selling model providing direct customer engagement.
What Are NUS's Weaknesses?
- Reliance on direct sales model, which can be vulnerable to regulatory changes.
- Relatively low profit margin compared to some competitors.
- Geographic concentration in certain markets, particularly Mainland China.
- Potential for negative publicity related to direct selling practices.
What Could Drive NUS Stock Higher?
- Launch of new skincare and nutritional products in Q3 2026.
- Expansion of e-commerce platform and digital marketing initiatives.
- Strategic partnerships to expand product portfolio and market reach.
What Are the Key Risks for NUS?
- Insider selling — insiders were net sellers of roughly $2.8M recently.
- Regulatory changes impacting direct selling practices.
- Economic downturns affecting consumer spending on discretionary items.
- Intense competition from established and emerging brands.
- Fluctuations in currency exchange rates impacting international sales.
What Are the Growth Opportunities for NUS?
- Expansion in Emerging Markets: Nu Skin has the opportunity to expand its presence in emerging markets, particularly in Asia, where demand for beauty and wellness products is rapidly growing. By tailoring its product offerings and marketing strategies to local preferences, Nu Skin can tap into new customer segments and drive revenue growth. The market size for beauty and wellness products in Asia is estimated to reach $500 billion by 2030, presenting a significant growth opportunity for Nu Skin.
- Product Innovation in Skincare: Nu Skin can capitalize on the growing demand for advanced skincare solutions by investing in research and development and launching innovative products. The company's ageLOC technology provides a competitive advantage in the anti-aging market. The global skincare market is projected to reach $180 billion by 2028, driven by increasing awareness of skincare benefits and the availability of advanced products.
- Digital Transformation and E-commerce: Nu Skin can enhance its online presence and e-commerce capabilities to reach a broader customer base and improve the customer experience. By investing in digital marketing, social media engagement, and online sales platforms, Nu Skin can drive online sales and reduce its reliance on direct sales channels. The global e-commerce market for beauty and wellness products is expected to reach $100 billion by 2027.
- Strategic Partnerships and Acquisitions: Nu Skin can pursue strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. By partnering with complementary businesses, Nu Skin can leverage synergies and accelerate its growth. The company could explore opportunities in personalized nutrition, wellness technology, and sustainable beauty.
- Personalized Nutrition and Wellness: Nu Skin can leverage the growing trend towards personalized nutrition and wellness by offering customized product recommendations and solutions based on individual needs and preferences. By collecting data on customer health and lifestyle, Nu Skin can develop targeted products and services that address specific health concerns. The global market for personalized nutrition is projected to reach $25 billion by 2025.
What Opportunities Does NUS Have?
- Expansion in emerging markets with growing demand for beauty and wellness products.
- Product innovation in skincare and personalized nutrition.
- Digital transformation and e-commerce growth.
- Strategic partnerships and acquisitions to expand product portfolio.
What Threats Does NUS Face?
- Changing consumer preferences and trends in the beauty and wellness market.
- Intense competition from established and emerging brands.
- Regulatory scrutiny of direct selling practices.
- Economic downturns impacting consumer spending on discretionary items.
What Are NUS's Competitive Advantages?
- Brand recognition and reputation in the beauty and wellness market.
- Proprietary ageLOC technology providing a competitive advantage in anti-aging.
- Established direct sales network and distributor relationships.
- Global distribution network reaching customers in multiple countries.
What Does NUS Do?
Founded in 1984 and headquartered in Provo, Utah, Nu Skin Enterprises, Inc. develops and distributes an extensive range of beauty and wellness products worldwide. The company's offerings include advanced skin care systems like the ageLOC Spa and ageLOC Transformation, along with devices such as the ageLOC LumiSpa. These products target anti-aging and skin treatment needs. In addition to skincare, Nu Skin provides nutritional supplements, including the ageLOC Youth and LifePak lines, and weight management systems like ageLOC TR90. The company also offers the Beauty Focus Collagen+ supplement. Nu Skin operates retail stores and service centers, particularly in Mainland China, and sells its products through direct sales, distributors, and its website. The company's brands include Nu Skin, Pharmanex, and ageLOC, reflecting its commitment to both beauty and wellness sectors. Nu Skin continues to invest in research and product development to stay competitive and meet evolving consumer demands.
What Products and Services Does NUS Offer?
- Develop and distribute skincare systems targeting anti-aging and skin treatment.
- Offer nutritional supplements focused on overall wellness and specific health benefits.
- Provide weight management and body shaping systems.
- Operate retail stores and service centers in select markets.
- Engage in research and product development for skincare and nutritional products.
- Sell products through direct sales, distributors, and online channels.
How Does NUS Make Money?
- Direct sales model leveraging distributors to reach customers.
- Online sales through the company's website.
- Retail operations in specific markets, particularly Mainland China.
- Subscription-based programs for recurring revenue.
What Industry Does NUS Operate In?
Nu Skin operates in the competitive household and personal products industry, characterized by evolving consumer preferences and intense competition. The global beauty and wellness market is driven by increasing disposable incomes and a growing emphasis on personal care. Nu Skin's direct selling model differentiates it from traditional retail brands, but also exposes it to unique regulatory and operational challenges. The company must continuously innovate and adapt to maintain its market position amid changing trends and competitive pressures.
Who Are NUS's Key Customers?
- Individuals seeking anti-aging and skincare solutions.
- Consumers interested in nutritional supplements and wellness products.
- Customers looking for weight management and body shaping systems.
- Distributors who sell Nu Skin products to their networks.
Company Profile
Nu Skin Enterprises, Inc. operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Provo, US. The company is led by CEO Ryan S. Napierski. NUS has traded publicly since 1996.
How Nu Skin Enterprises, Inc. Is Valued
Nu Skin Enterprises, Inc. carries a market capitalization of $244.21M, placing it in the micro-cap category. Relative to its peer group, NUS's quantitative score of 78/100 is above the peer average of 57/100.
ROE 7%Key Financial Metrics
Return on equity for Nu Skin Enterprises, Inc. stands at 6.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.0%, showing how much profit it generates from its asset base. NUS trades at a trailing price-to-earnings ratio of 4.73, below the Consumer Defensive sector average of ~29x. Its free cash flow yield is 16.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.03 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 21.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Nu Skin Enterprises, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.61 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Nu Skin Enterprises, Inc. revenue of about $1.43B for fiscal 2026, with EPS near $1.00.
Net buyingInsider Activity
Over the past six months, Nu Skin Enterprises, Inc. insiders filed 28 SEC Form 4 transactions — 11 sales and 17 purchases. On net that is roughly 817K shares acquired (about $2.8M) — insiders putting money in tends to read as conviction.
NUS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Nu Skin's direct selling model seems to be resonating with a segment of consumers seeking personalized beauty and wellness solutions, creating a loyal customer base.
- Insider activity suggests confidence in the company's long-term strategy, as key executives are actively involved.
- Social sentiment indicates a growing interest in Nu Skin's innovative product lines, particularly in the anti-aging and wellness categories.
- The company's global expansion efforts, especially in emerging markets, could unlock new growth opportunities and revenue streams.
Bear Case
- The direct selling industry faces increasing scrutiny and regulatory challenges, potentially impacting Nu Skin's operational model and profitability.
- Community sentiment reveals concerns about the sustainability of Nu Skin's growth, given the competitive landscape and evolving consumer preferences.
- Market perception suggests that Nu Skin's brand image may need revitalization to attract younger demographics and stay relevant in the digital age.
- Recent insider activity, while generally positive, may also reflect strategic adjustments in response to market headwinds, adding a layer of uncertainty.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
NUS Latest News
-
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
seekingalpha.com · Jun 30, 2026
-
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
zacks.com · Jun 29, 2026
-
Zacks Industry Outlook Highlights Estee Lauder, e.l.f. Beauty, Helen of Troy and Nu Skin
Zacks · Jun 18, 2026
-
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
zacks.com · Jun 16, 2026
NUS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NUS.
Price Targets
Wall Street price target analysis for NUS.
NUS MoonshotScore
What does this score mean?
The MoonshotScore rates NUS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
Zacks Industry Outlook Highlights Estee Lauder, e.l.f. Beauty, Helen of Troy and Nu Skin
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
Leadership: Ryan S. Napierski
President and Chief Executive Officer
Ryan S. Napierski has served as President and Chief Executive Officer of Nu Skin Enterprises since 2021. He has been with the company for over 25 years, holding various leadership positions in sales, marketing, and operations. Napierski holds a bachelor's degree in business, a master's degree in business administration (MBA) from Duke University's Fuqua School of Business, and an international business certificate from Georgetown University.
Track Record: Under Napierski's leadership, Nu Skin has focused on enhancing its digital capabilities and expanding its product offerings in the personalized nutrition and wellness space. He has also overseen the company's efforts to navigate regulatory challenges and adapt to changing consumer preferences. Key milestones include the launch of new ageLOC products and the expansion of the company's e-commerce platform.
NUS Consumer Defensive Stock FAQ
What does Nu Skin Enterprises, Inc. do?
Nu Skin Enterprises, Inc. develops and distributes a range of beauty and wellness products, including skincare systems, nutritional supplements, and weight management products. The company operates through a direct selling model, utilizing distributors and online channels to reach customers globally. Nu Skin focuses on innovation and product development to maintain its competitive edge in the consumer defensive sector, particularly in the household and personal products industry. The company's key brands include Nu Skin, Pharmanex, and ageLOC.
What do analysts say about NUS stock?
Analyst coverage of Nu Skin Enterprises, Inc. (NUS) is mixed, with some highlighting the company's potential for growth in emerging markets and its strong brand recognition. However, concerns remain regarding the company's reliance on the direct selling model and its exposure to regulatory risks. Key valuation metrics, such as the P/E ratio and dividend yield, suggest potential value, but investors should carefully consider the company's growth prospects and risk factors. Analyst ratings and price targets vary, reflecting differing views on the company's future performance.
What are the main risks for NUS?
Nu Skin Enterprises, Inc. faces several key risks, including regulatory scrutiny of its direct selling practices, changing consumer preferences in the beauty and wellness market, and intense competition from established and emerging brands. Economic downturns could also impact consumer spending on discretionary items, affecting Nu Skin's sales. Additionally, fluctuations in currency exchange rates could negatively impact the company's international sales and profitability. Investors should carefully assess these risks before investing in NUS.
What are the key factors to evaluate for NUS?
Nu Skin Enterprises, Inc. (NUS) holds an AI score of 78/100 (high). P/E: 4.7x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does NUS data refresh on this page?
NUS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NUS's recent stock price performance?
Nu Skin Enterprises, Inc. (NUS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand recognition in the beauty and wellness industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NUS overvalued or undervalued right now?
Nu Skin Enterprises, Inc. (NUS) trades at 4.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NUS?
Before investing in Nu Skin Enterprises, Inc. (NUS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Analysis is for informational purposes only and does not constitute investment advice.